EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction—A systematic review

Saiko Sugita iD, Peggy Tahir, Sakura Kinjo iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281049 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS ONE, 2023. Verfasst von Saiko Sugita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Nippon Medical School, Tama-Nagayama Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Postoperative Cognitive Complications, Cognitive Dysfunction, Microbiota. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The gut-brain axis involves bidirectional communication between the gut-microbiota and central nervous system. This study aimed to investigate whether probiotics and/or prebiotics, known as Microbiome-targeted Therapies (MTTs), improve cognition and prevent postoperative cognitive dysfunction (POCD).

Methods

Relevant animal and human studies were identified using a systematic database search (PubMed, EMBASE, Cochrane Library, and Web of Science), focusing on the effects of MTTs on inflammation, perioperative and non-perioperative cognitive impairment. Screening and data extraction were conducted by two independent reviewers. The Risk of bias was assessed using the SYRCLE’s risk of bias tool for animal studies. The revised Cochrane risk of bias tool (RoB 2) was used for human studies.

Results

A total of 24 articles were selected; 16 of these involved animal studies, and 8 described studies in humans. In these papers, the use of MTTs consistently resulted in decreased inflammation in perioperative and non-perioperative settings. Out of 16 animal studies, 5 studies (2 associated with delirium and 3 studies related to POCD) were conducted in a perioperative setting. MTTs improved perioperative cognitive behavior and reduced inflammation in all 5 animal studies. Eleven animal studies were conducted in a non-perioperative setting. In all of these studies, MTTs showed improvement in learning and memory function. MTTs showed a positive effect on levels of pro-inflammatory cytokines and biomarkers related to cognitive function. Among the 8 human studies, only one study examined the effects of perioperative MTTs on cognitive function. This study showed a reduced incidence of POCD along with improved cognitive function. Of the remaining 7 studies, 6 suggested that MTTs improved behavioral test results and cognition in non-perioperative environments. One study failed to show any significant differences in memory, biomarkers of inflammation, or oxidative factors.

Conclusion

In the studies we examined, most showed that MTTs decrease inflammation by down-regulating inflammatory cytokines and oxidative stress in both perioperative and non-perioperative settings. In general, MTTs also seem to have a positive effect on cognition through neural, immune, endocrine, and metabolic pathways. However, these effects have not yet resulted in a consensus regarding preventative strategies or treatments. Based on these current research results, MTTs could be a potential new preventative strategy for cognitive impairment after surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postoperative Cognitive ComplicationsCognitive DysfunctionMicrobiotaAnimalsHumansPostoperative ComplicationsInflammationCytokinesBiomarkers

Substanzen

CytokinesBiomarkers

Autor:innen und Institutionen

  • Department of Anesthesiology, Nippon Medical School, Tama-Nagayama Hospital, Tokyo, Japan.
  • University of California San Francisco Library, University of California, San Francisco, San Francisco, California, United States of America.
  • Department of Anesthesiology and Perioperative Care, University of California, San Francisco, San Francisco, California, United States of America.

ORCID-Profile: Saiko Sugita, Sakura Kinjo

Zitieren

APA

Sugita, S., Tahir, P., & Kinjo, S. (2023). The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction—A systematic review. PLOS ONE. https://doi.org/10.1371/journal.pone.0281049

Vancouver

Sugita S, Tahir P, Kinjo S. The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction—A systematic review. PLOS ONE. 2023. doi:10.1371/journal.pone.0281049

BibTeX
@article{Sugita2023,
  author = {Sugita, Saiko and Tahir, Peggy and Kinjo, Sakura},
  title = {The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction—A systematic review},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281049}
}
Kostenlos starten →